PASITHEA THERAPEUTICS CORP. Disposal Group, Including Discontinued Operation, Revenue
PASITHEA THERAPEUTICS CORP. (KTTA) reported Disposal Group, Including Discontinued Operation, Revenue of $486.56 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-29.
Discontinued › Income Statement › Other Income
us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue · last filed 2024-03-29
- PASITHEA THERAPEUTICS CORP. disposal group, including discontinued operation, revenue for the quarter ending 2022-12-31 was $240.71K.
- PASITHEA THERAPEUTICS CORP. disposal group, including discontinued operation, revenue for the quarter ending 2022-09-30 was $218.61K.
- PASITHEA THERAPEUTICS CORP. disposal group, including discontinued operation, revenue for the quarter ending 2022-06-30 was $13.58K.
- PASITHEA THERAPEUTICS CORP. disposal group, including discontinued operation, revenue for fiscal 2022 was $486.56K.
| Period end | Disposal Group, Including Discontinued Operation, Revenue 3 month | Disposal Group, Including Discontinued Operation, Revenue 6 month | Disposal Group, Including Discontinued Operation, Revenue 9 month | Disposal Group, Including Discontinued Operation, Revenue 12 month |
|---|---|---|---|---|
| 2022-12-31 | $240.71K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $459.32K derived: sum of 2 quarters · filed 2024-03-29 | $472.90K derived: sum of 3 quarters · filed 2024-03-29 | $486.56K 10-K · filed 2024-03-29 |
| 2022-09-30 | $218.61K 10-Q · filed 2023-11-13 | $232.19K derived: sum of 2 quarters · filed 2023-11-13 | $245.85K 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $13.58K 10-Q · filed 2023-08-11 | $27.24K 10-Q · filed 2023-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |